litlas
Log inCreate account

Thomas A. Fleisher

Active 1980–2025

104
Papers
24,011
Citations
85
h-index
103
i10-index

Citations

Citations per year for Thomas A. Fleisher1982: 3 citations1983: 2 citations1984: 2 citations1985: 1 citations1986: 2 citations1987: 1 citations1988: 1 citations1989: 2 citations1990: 2 citations1991: 6 citations1992: 8 citations1993: 9 citations1994: 15 citations1995: 13 citations1996: 40 citations1997: 55 citations1998: 89 citations1999: 114 citations2000: 112 citations2001: 117 citations2002: 109 citations2003: 88 citations2004: 79 citations2005: 96 citations2006: 106 citations2007: 95 citations2008: 82 citations2009: 133 citations2010: 141 citations2011: 137 citations2012: 124 citations2013: 111 citations2014: 174 citations2015: 282 citations2016: 266 citations2017: 296 citations2018: 303 citations2019: 848 citations2020: 815 citations2021: 864 citations2022: 565 citations2023: 454 citations2024: 639 citations2025: 228 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,008 citing papers, 28.3% of this breakdownChina: 756 citing papers, 7.1% of this breakdownUnited Kingdom: 735 citing papers, 6.9% of this breakdownGermany: 623 citing papers, 5.9% of this breakdownFrance: 615 citing papers, 5.8% of this breakdownItaly: 487 citing papers, 4.6% of this breakdownCanada: 344 citing papers, 3.2% of this breakdownJapan: 324 citing papers, 3.1% of this breakdownNetherlands: 306 citing papers, 2.9% of this breakdownAustralia: 294 citing papers, 2.8% of this breakdownSwitzerland: 246 citing papers, 2.3% of this breakdownSpain: 228 citing papers, 2.2% of this breakdown
0%28.3%Other 24.9%

Institutions

Fields

  • Immunology and Microbiology40.6%
  • Medicine38.1%
  • Biochemistry, Genetics and Molecular Biology18.6%
  • Neuroscience0.7%
  • Pharmacology, Toxicology and Pharmaceutics0.4%
  • Engineering0.3%
  • Other1.3%

Topics

  • Immune Cell Function and Interaction8.1%
  • Immunodeficiency and Autoimmune Disorders5.6%
  • T-cell and B-cell Immunology5%
  • CAR-T cell therapy research4.1%
  • Inflammasome and immune disorders3.6%
  • interferon and immune responses3.3%
  • Other70.3%

Coauthors

All papers

Open in search
  1. Activated STING in a Vascular and Pulmonary Syndrome

    Authors: Yu Liu, Adriana A. de Jesus, Bernadette Marrero, Dan Yang, Suzanne Ramsey, Gina A. Montealegre Sanchez, Klaus Tenbrock, Helmut Wittkowski, Olcay Y. Jones, Hyesun Kuehn, Chyi‐Chia Richard Lee, Michael A. DiMattia, Edward W. Cowen, B González, Ira Palmer, John J. DiGiovanna, Angélique Biancotto, Hanna Kim, Wen Lin Tsai, Anna M. Trier, Yan Huang, Deborah L. Stone, Suvimol Hill, HyeSoon Kim, Cynthia St. Hilaire, Shakuntala Gurprasad, N Plass, Dawn Chapelle, Iren Horkayne‐Szakaly, Dirk Foell, Andrei Barysenka, Fabio Candotti, Steven M. Holland, Jason D. Hughes, Huseyin Mehmet, Andrew C. Issekutz, M Raffeld, Joshua McElwee, JÉRǑMe Fontana, Caterina P. Minniti, Susan Moir, Daniel L. Kastner, Massimo Gadina, A.C. Steven, Paul T. Wingfield, Stephen R. Brooks, Sergio D. Rosenzweig, Thomas A. Fleisher, Zuoming Deng, Manfred Boehm, Amy S. Paller, Raphaela Goldbach‐Mansky - New England Journal of Medicine 2014 cited by 1,387

  2. Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer

    Authors: Kevin C. Conlon, Enrico Lugli, Hugh C. Welles, Steven A. Rosenberg, Antonio Tito Fojo, John C. Morris, Thomas A. Fleisher, Sigrid Dubois, Liyanage P. Perera, Donn M. Stewart, Carolyn K. Goldman, Bonita R. Bryant, Jean M. Decker, Jing Chen, Tatyana Worthy, William D. Figg, Cody J. Peer, Michael C. Sneller, H. Clifford Lane, Jason L. Yovandich, Stephen P. Creekmore, Mario Roederer, Thomas A. Waldmann - Journal of Clinical Oncology 2014 cited by 702

  3. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome

    Authors: Scott Canna, Adriana A. de Jesus, Sushanth Gouni, Stephen R. Brooks, Bernadette Marrero, Yin Liu, Michael A. DiMattia, Kristien J.M. Zaal, Gina A. Montealegre Sanchez, Hanna Kim, Dawn Chapelle, Nicole Plass, Yan Huang, Alejandro V. Villarino, Angélique Biancotto, Thomas A. Fleisher, Joseph A. Duncan, John J. O’Shea, Susanne M. Benseler, Alexei A. Grom, Zuoming Deng, Ronald M. Laxer, Raphaela Goldbach‐Mansky - Nature Genetics 2014 cited by 735

  4. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4

    Authors: Hye Sun Kuehn, Weiming Ouyang, Bernice Lo, Elissa K. Deenick, Julie E. Niemela, Danielle T. Avery, Jean-Nicolas Schickel, Dat Q. Tran, Jennifer Stoddard, Yu Zhang, David M. Frucht, Bogdan Dumitriu, Phillip Scheinberg, Les Folio, Cathleen Frein, Susan Price, Christopher Koh, Theo Heller, Christine M. Seroogy, Anna Huttenlocher, V. Koneti Rao, Helen C. Su, David E. Kleiner, Luigi D. Notarangelo, Yajesh Rampertaap, Kenneth N. Olivier, Joshua McElwee, Jason D. Hughes, Stefania Pittaluga, João Bosco Oliveira, Eric Meffre, Thomas A. Fleisher, Steven M. Holland, Michael J. Lenardo, Stuart G. Tangye, Gülbû Uzel - Science 2014 cited by 855

  5. T Lymphocyte-Directed Gene Therapy for ADA − SCID: Initial Trial Results After 4 Years

    Authors: R. Michael Blaese, Kenneth W. Culver, A. Dusty Miller, Charles S. Carter, Thomas A. Fleisher, Mario Clerici, Gene M. Shearer, Lauren A. Chang, Ya‐Wen Chiang, Paul Tolstoshev, Jay J. Greenblatt, Steven A. Rosenberg, Harvey G. Klein, Melvin Berger, Craig A. Mullen, W. Jay Ramsey, Linda Muul, Richard A. Morgan, W. French Anderson - Science 1995 cited by 1,519

  6. Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009

    Authors: Sung‐Yun Pai, Brent R. Logan, Linda M. Griffith, Rebecca H. Buckley, Roberta Parrott, Christopher C. Dvorak, Neena Kapoor, I. Celine Hanson, Alexandra H. Filipovich, Soma Jyonouchi, Kathleen E. Sullivan, Trudy N. Small, Lauri M. Burroughs, Suzanne Skoda‐Smith, Ann E. Haight, Audrey Grizzle, Michael A. Pulsipher, Ka Wah Chan, Ramsay Fuleihan, Élie Haddad, Brett Loechelt, Victor M. Aquino, Alfred P. Gillio, Jeffrey Davis, Alan P. Knutsen, Angela R. Smith, Theodore B. Moore, Marlis L. Schroeder, Frederick D. Goldman, James A. Connelly, Matthew H. Porteus, Qun Xiang, William T. Shearer, Thomas A. Fleisher, Donald B. Kohn, Jennifer M. Puck, Luigi D. Notarangelo, Morton J. Cowan, Richard J. O’Reilly - New England Journal of Medicine 2014 cited by 771

  7. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency

    Authors: C. Lucas, Hye Sun Kuehn, Fang Zhao, Julie E. Niemela, Elissa K. Deenick, Umaimainthan Palendira, Danielle T. Avery, Leen Moens, Jennifer L. Cannons, Matthew Biancalana, Jennifer Stoddard, Weiming Ouyang, David M. Frucht, V. Koneti Rao, T. Prescott Atkinson, Anahita Agharahimi, Ashleigh A. Hussey, Les Folio, Kenneth N. Olivier, Thomas A. Fleisher, Stefania Pittaluga, Steven M. Holland, Jeffrey I. Cohen, João Bosco Oliveira, Stuart G. Tangye, Pamela L. Schwartzberg, Michael J. Lenardo, Gülbû Uzel - Nature Immunology 2013 cited by 664

  8. Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2

    Authors: Qing Zhou, Dan Yang, Amanda K. Ombrello, Andrey V. Zavialov, Camilo Toro, Anton V. Zavialov, Deborah L. Stone, Jae Jin Chae, Sergio D. Rosenzweig, Kevin Bishop, Karyl S. Barron, Hye Sun Kuehn, Patrycja Hoffmann, Alejandra Negro, Wanxia Li Tsai, Edward W. Cowen, Wuhong Pei, Joshua D. Milner, Christopher Silvin, Theo Heller, David T. Chin, Nicholas J. Patronas, John S. Barber, Chyi‐Chia Richard Lee, Geryl Wood, Alexander Ling, Susan J. Kelly, David E. Kleiner, James C. Mullikin, Nancy J. Ganson, Heidi H. Kong, Sophie Hambleton, Fabio Candotti, Martha Quezado, Katherine R. Calvo, Hawwa Alao, Beverly Barham, Anne Jones, James F. Meschia, Bradford B. Worrall, Scott E. Kasner, Stephen S. Rich, Raphaela Goldbach‐Mansky, Mario Abinun, Elizabeth Chalom, Alisa Gotte, Marilynn Punaro, Virginia Pascual, James Verbsky, Troy R. Torgerson, Nora G. Singer, Timothy R. Gershon, Seza Özen, Ömer Karadağ, Thomas A. Fleisher, Elaine F. Remmers, Shawn M. Burgess, Susan Moir, Massimo Gadina, Raman Sood, Michael S. Hershfield, Manfred Boehm, Daniel L. Kastner, Ivona Aksentijevich - New England Journal of Medicine 2014 cited by 893

  9. IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion

    Authors: Kevin C. Conlon, E. Lake Potter, Stefania Pittaluga, Chyi‐Chia Richard Lee, Miloš D. Miljković, Thomas A. Fleisher, Sigrid Dubois, Bonita R. Bryant, Michael Petrus, Liyanage P. Perera, Jennifer L. Hsu, William D. Figg, Cody J. Peer, Joanna H. Shih, Jason L. Yovandich, Stephen P. Creekmore, Mario Roederer, Thomas A. Waldmann - Clinical Cancer Research 2019 cited by 133

  10. The microbiome in allergic disease: Current understanding and future opportunities—2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology

    Authors: Yvonne J. Huang, Benjamin J. Marsland, Supinda Bunyavanich, Liam O’Mahony, Donald Y.M. Leung, Antonella Muraro, Thomas A. Fleisher - Journal of Allergy and Clinical Immunology 2017 cited by 326

  11. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop

    Authors: João Bosco Oliveira, Jack Bleesing, Umberto Dianzani, Thomas A. Fleisher, Elaine S. Jaffe, Michael J. Lenardo, Frédéric Rieux‐Laucat, Richard M. Siegel, Helen C. Su, David T. Teachey, V. Koneti Rao - Blood 2010 cited by 486

  12. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets

    Authors: Claude Sportès, Frances T. Hakim, Sarfraz Memon, Hua Zhang, Kevin Chua, Margaret R. Brown, Thomas A. Fleisher, Michael Krumlauf, Rebecca Babb, Catherine K. Chow, Terry J. Fry, Julie Engels, Renaud Buffet, Michel Morre, Robert J. Amato, David Venzon, Robert Korngold, Andrew L. Pecora, Ronald E. Gress, Crystal L. Mackall - The Journal of Experimental Medicine 2008 cited by 467

  13. Apoptosis

    Authors: Thomas A. Fleisher - Annals of Allergy Asthma & Immunology 1997 cited by 133

  14. Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell–depleted stem cell transplantation

    Authors: Nirali N. Shah, Kristin Baird, Cynthia Delbrook, Thomas A. Fleisher, M. Eric Kohler, Shakuntala Rampertaap, Kimberly Lemberg, Carolyn Katovich Hurley, David E. Kleiner, Melinda S. Merchant, Stefania Pittaluga, Marianna Sabatino, David F. Stroncek, Alan S. Wayne, Hua Zhang, Terry J. Fry, Crystal L. Mackall - Blood 2014 cited by 235

  15. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency

    Authors: David Boutboul, Hye Sun Kuehn, Zoé Van de Wyngaert, Julie E. Niemela, Isabelle Callebaut, Jennifer Stoddard, Christelle Lenoir, Vincent Barlogis, Catherine Farnarier, Frédéric Vely, Nao Yoshida, Seiji Kojima, Hirokazu Kanegane, Akihiro Hoshino, Fabian Hauck, Ludovic Lhermitte, Vahid Asnafi, Philip Roehrs, Shaoying Chen, James Verbsky, Katherine R. Calvo, Ammar Husami, Kejian Zhang, Joseph L. Roberts, David J. Amrol, John Sleaseman, Amy P. Hsu, Steven M. Holland, Rebecca Marsh, Alain Fischer, Thomas A. Fleisher, Capucine Pïcard, Sylvain Latour, Sergio D. Rosenzweig - Journal of Clinical Investigation 2018 cited by 164

  16. Immune reconstitution and survival of 100 SCID patients post–hematopoietic cell transplant: a PIDTC natural history study

    Authors: Jennifer Heimall, Brent R. Logan, Morton J. Cowan, Luigi D. Notarangelo, Linda M. Griffith, Jennifer M. Puck, Donald B. Kohn, Michael A. Pulsipher, Suhag Parikh, Caridad Martinez, Neena Kapoor, Richard J. O’Reilly, Michael Boyer, Sung‐Yun Pai, Frederick D. Goldman, Lauri Burroughs, Sharat Chandra, Morris Kletzel, Monica S. Thakar, James A. Connelly, Geoff D.E. Cuvelier, Blachy J. Dávila Saldaña, Evan Shereck, Alan P. Knutsen, Kathleen E. Sullivan, Kenneth B. DeSantes, Alfred P. Gillio, Élie Haddad, Aleksandra Petrović, Troy C. Quigg, Angela R. Smith, Elizabeth Stenger, Ziyan Yin, William T. Shearer, Thomas A. Fleisher, Rebecca H. Buckley, Christopher C. Dvorak - Blood 2017 cited by 266

  17. Loss of B Cells in Patients with Heterozygous Mutations in IKAROS

    Authors: Hye Sun Kuehn, Bertrand Boisson, Charlotte Cunningham‐Rundles, Janine Reichenbach, Asbjørg Stray‐Pedersen, Erwin W. Gelfand, Patrick Maffucci, Keith R. Pierce, Jordan K. Abbott, Karl V. Voelkerding, Sarah T. South, Nancy H. Augustine, Jeana S. Bush, William K. Dolen, Betty B. Wray, Yuval Itan, Aurélie Cobat, Hanne Sørmo Sorte, Sundar Ganesan, Seraina Prader, Thomas B. Martins, Monica G. Lawrence, Jordan S. Orange, Katherine R. Calvo, Julie E. Niemela, Jean‐Laurent Casanova, Thomas A. Fleisher, Harry R. Hill, Attila Kumánovics, Mary Ellen Conley, Sergio D. Rosenzweig - New England Journal of Medicine 2016 cited by 245

  18. Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open‐label phase I dosage‐escalation study

    Authors: Gabor G. Illei, Yuko Shirota, Cheryl Yarboro, Jimmy Daruwalla, Edward Tackey, Kazuki Takada, Thomas A. Fleisher, James E. Balow, Peter E. Lipsky - Arthritis & Rheumatism 2010 cited by 505

  19. Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques

    Authors: Thomas A. Waldmann, Enrico Lugli, Mario Roederer, Liyanage P. Perera, Jeremy Smedley, Rhonda MacAllister, Carolyn K. Goldman, Bonita R. Bryant, Jean M. Decker, Thomas A. Fleisher, H. Clifford Lane, Michael C. Sneller, Roger Kurlander, David E. Kleiner, J. M. Pletcher, William D. Figg, Jason L. Yovandich, Stephen P. Creekmore - Blood 2011 cited by 194

  20. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy

    Authors: Elise M. N. Ferré, Stacey Rose, Sergio D. Rosenzweig, Peter D. Burbelo, Kimberly Romito, Julie E. Niemela, Lindsey B. Rosen, Timothy J. Break, Wenjuan Gu, Sally Hunsberger, Sarah Browne, Amy P. Hsu, Shakuntala Rampertaap, Muthulekha Swamydas, Amanda L. Collar, Heidi H. Kong, Chyi‐Chia Richard Lee, David M. Chascsa, Thomas L. Simcox, Angela Pham, Anamaria Bondici, Mukil Natarajan, Joseph Monsale, David E. Kleiner, Martha Quezado, Ilias Alevizos, Niki M. Moutsopoulos, Lynne Yockey, Cathleen Frein, Ariane Soldatos, Katherine R. Calvo, Jennifer Adjemian, Morgan Similuk, David M. Lang, Kelly D. Stone, Gülbû Uzel, Jeffrey B. Kopp, Rachel Bishop, Steven M. Holland, Kenneth N. Olivier, Thomas A. Fleisher, Theo Heller, Karen K. Winer, Michail S. Lionakis - JCI Insight 2016 cited by 304

  21. The importance of allergic disease in public health: an iCAALL statement

    Authors: Mario Sánchez‐Borges, Bryan Martin, Antonella Muraro, Robert A. Wood, Ioana Agache, Ignacio J. Ansotegui, Thomas B. Casale, Thomas A. Fleisher, Peter W. Hellings, Nikolaos G. Papadopoulos, David B. Peden, James L. Sublett, Stephen A. Tilles, Lanny J. Rosenwasser - World Allergy Organization Journal 2018 cited by 101

  22. Identification of germline monoallelic mutations in IKZF2 in patients with immune dysregulation

    Authors: Tala Shahin, Daniel Mayr, Mohamed R. Shoeb, Hye Sun Kuehn, Birgit Hoeger, Sarah Giuliani, Lisa Gawriyski, Özlem Yüce Petronczki, Jérôme Hadjadj, Sevgi Köstel Bal, Samaneh Zoghi, Matthias Haimel, Raúl Jiménez Heredia, David Boutboul, Michael Triebwasser, Fanny Rialland, Nathalie Costedoat Chalumeau, Pierre Quartier, Stuart G. Tangye, Thomas A. Fleisher, Nima Rezaei, Neil Romberg, Sylvain Latour, Markku Varjosalo, Florian Halbritter, Frédéric Rieux‐Laucat, Irinka Castanon, Sergio D. Rosenzweig, Kaan Boztuǧ - Blood Advances 2021 cited by 53

  23. BCG vaccination in patients with severe combined immunodeficiency: Complications, risks, and vaccination policies

    Authors: Beatriz E. Marciano, Chiung‐Yu Huang, Gyan Joshi, Nima Rezaei, Beatriz Costa Carvalho, Zoe Allwood, Aydan İkincioğulları, Shereen M. Reda, Andrew R. Gennery, Vojtěch Thon, Francisco Espinosa‐Rosales, Waleed Al–Herz, Óscar Porras, Anna Shcherbina, Anna Szaflarska, Şebnem Kiliç, José Luis Franco, Andrea Cecilia Gómez Raccio, Pérsio Roxo Júnior, Isabel Esteves, Nermeen Galal, Anete Sevciovic Grumach, Salem Al‐Tamemi, Alişan Yıldıran, Julio César Orellana, Masafumi Yamada, Tomohiro Morio, Diana Liberatore, Yoshitoshi Ohtsuka, YL Lau, Ryuta Nishikomori, Carlos Torres-Lozano, Juliana Themudo Lessa Mazzucchelli, Maria Marluce S. Vilela, Fabíola Scancetti Tavares, Luciana Cristina Matos Cunha, Jorge Pinto, Sara Elva Espinosa‐Padilla, Leticia Hernández-Nieto, Reem Elfeky, Tadashi Ariga, Toshio Heike, Figen Doğu, Funda Çipe, Renata Formánková, María Núñez‐Núñez, Liliana Bezrodnik, José Gonçalo Marques, Maria ines Pereira, Viviana Listello, Mary Slatter, Zohreh Nademi, Danuta Kowalczyk, Thomas A. Fleisher, Graham Davies, Bénédicte Neven, Sergio D. Rosenzweig - Journal of Allergy and Clinical Immunology 2014 cited by 262

  24. Phase I Study of Recombinant Human Interleukin-7 Administration in Subjects with Refractory Malignancy

    Authors: Claude Sportès, Rebecca Babb, Michael Krumlauf, Frances T. Hakim, Seth M. Steinberg, Catherine K. Chow, Margaret R. Brown, Thomas A. Fleisher, Pierre Noël, Irina Marić, Maryalice Stetler‐Stevenson, J Engel, Renaud Buffet, Michel Morre, Robert J. Amato, Andrew L. Pecora, Crystal L. Mackall, Ronald E. Gress - Clinical Cancer Research 2010 cited by 222